Serotherapy of a patient with a monoclonal antibody directed against a human lymphoma-associated antigen
about
Recent advances in the field of anti-cancer immunotherapyRituximab: how approval history is reflected by a corresponding patent filing strategyFrom monoclonal antibodies to chimeric antigen receptors for the treatment of human malignanciesImproving the treatment of non-Hodgkin lymphoma with antibody-targeted radionuclides.Monoclonal antibodies--therapeutic and diagnostic uses in malignancy.Dynamic studies of lymphocytes labelled with indium-111 during and after treatment with monoclonal anti-idiotype antibody in advanced B cell lymphomaRituximab for non-Hodgkin's lymphoma: a story of rapid success in translation.N,N,N-Trimethyl chitosan nanoparticles for the delivery of monoclonal antibodies against hepatocellular carcinoma cells.Harnessing gene conversion in chicken B cells to create a human antibody sequence repertoire.Monoclonal antibodies in gynecological cancer: a critical point of view.Building better monoclonal antibody-based therapeutics.Mechanisms of tumour cell escape encountered in treating lymphocytic leukaemia with anti-idiotypic antibodyPharmacokinetics and tolerability of human mouse chimeric anti-CD22 monoclonal antibody in Chinese patients with CD22-positive non-Hodgkin lymphoma.Characterization of a monoclonal antibody to L1210 leukaemia.Localisation and toxicity study of a vindesine-anti-CEA conjugate in patients with advanced cancer.Monoclonal antibody to transferrin receptor blocks transferrin binding and inhibits human tumor cell growth in vitro.In vivo therapy of a murine B cell tumor (BCL1) using antibody-ricin A chain immunotoxins.Therapy of murine leukemia with monoclonal antibody against a normal differentiation antigen.Spontaneous release of the Leu-2 (T8) molecule from human T cellsSuccessful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4.Mechanism of recovery from acute virus infection: treatment of lymphocytic choriomeningitis virus-infected mice with monoclonal antibodies reveals that Lyt-2+ T lymphocytes mediate clearance of virus and regulate the antiviral antibody response.Monoclonal antibodies that prevent adhesion of B 16 melanoma cells and reduce metastases in mice: crossreaction with human tumor cells.Passive immunotherapeutic strategies for the treatment of malignant gliomas.Radioimmunotherapy of non-Hodgkin's lymphoma: from the 'magic bullets' to 'radioactive magic bullets'.Targeted drug delivery for cancer therapy: the other side of antibodies.Monoclonal antibodies in oncology.Radioimmunotherapy of malignancy using antibody targeted radionuclidesImmune guided missiles.A vindesine-anti-CEA conjugate cytotoxic for human cancer cells in vitro.Antibody-dependent-cellular-cytotoxicity against cultured human breast cancer cells mediated by human effector cells using monoclonal and polyclonal antibodies.Rituximab in the treatment of non-Hodgkin's lymphomaIn vivo T cell tumor therapy with monoclonal antibody directed to the V beta chain of T cell antigen receptor.Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience.Past, Present, and Future of Rituximab-The World's First Oncology Monoclonal Antibody Therapy.
P2860
Q26775602-220E9784-6D73-4125-87F8-6B1D971C1F47Q26821872-26D42481-CC7C-4240-B6DF-FA08AA63F74CQ26852919-E735C5E9-E1C0-44D5-A68E-F178C0A5DCD5Q33645793-21D0FAB8-EE93-476C-959E-5984DEF84730Q34193200-A79034A9-6110-4173-96F9-1E613444853CQ34553568-E7F3DCB4-78EF-4804-B10A-1DA65596E396Q34687563-87BD35AA-5097-455F-8DA5-D27689C60C92Q34935175-F9202E6B-9822-4898-BF36-657D6516193CQ35053450-FCBA5AFF-F30F-429B-A661-B88BAC27E98EQ35659915-7199351B-F645-4DE4-ADBB-3F099AE97D3BQ35817552-A437B78D-3333-432C-BA35-62F308960A92Q35991384-756A4264-8382-4E38-8933-8F3C669995CBQ35992515-E72D7EBF-CB83-469E-9BFE-A661AE59A4EBQ36046139-7FA5CA17-C305-4F35-A1A0-A2792A92C5A1Q36047395-262F3177-BDC3-40F1-ADCF-E07C8B08C60AQ36282608-592C5692-2E43-41F4-A3E6-D0A08FBE246BQ36346564-96D84D3A-6FC8-4F02-A678-BC8D6FB6C5A4Q36347559-F6E7A5BF-7CC3-46A2-995D-DFFA1638C582Q36348062-2AF93ECA-1F74-434D-A600-B75A605CA503Q36349869-D2B04221-E231-4E80-9EA3-C13E28264E10Q36888736-FA209EE0-D4EE-44DA-B593-C9370FA1CE36Q37511394-CAC38AE9-FD38-41EC-BBE3-E3BB343EB904Q37714783-D14AA829-650C-4380-B8AF-8EBA56AD6C51Q37969746-91950825-6D00-4B27-9C2B-64F29626C41EQ38058816-565ADB26-5E6A-4F5D-95DE-59764A738871Q39488591-0A016B06-3C92-49B4-B22B-5881AACD3EA5Q39754071-159AB352-3735-434C-B7F1-312308A94029Q41433857-E90E4187-D856-4CD3-906D-AA39535C28B0Q41490919-6EFE3CBC-DC97-4BF7-854C-B31082DE92E2Q41513539-8013F403-3697-41B8-9292-D33AEC37A562Q41925899-FCDE2F1B-9A11-4EFB-A753-0C821671133EQ42239294-C0D9A34F-BF83-415D-96E1-B07240BAAAC0Q46675870-C9D64E27-48F7-4308-A843-F6D3C2158384Q55283747-BF2FCD0E-321C-4808-B192-2380DAD7E79B
P2860
Serotherapy of a patient with a monoclonal antibody directed against a human lymphoma-associated antigen
description
1980 nî lūn-bûn
@nan
1980 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1980 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
name
Serotherapy of a patient with ...... an lymphoma-associated antigen
@ast
Serotherapy of a patient with ...... an lymphoma-associated antigen
@en
Serotherapy of a patient with ...... an lymphoma-associated antigen
@nl
type
label
Serotherapy of a patient with ...... an lymphoma-associated antigen
@ast
Serotherapy of a patient with ...... an lymphoma-associated antigen
@en
Serotherapy of a patient with ...... an lymphoma-associated antigen
@nl
prefLabel
Serotherapy of a patient with ...... an lymphoma-associated antigen
@ast
Serotherapy of a patient with ...... an lymphoma-associated antigen
@en
Serotherapy of a patient with ...... an lymphoma-associated antigen
@nl
P2093
P1433
P1476
Serotherapy of a patient with ...... an lymphoma-associated antigen
@en
P2093
Schlossman SF
Stashenko P
P304
P407
P50
P577
1980-09-01T00:00:00Z